197 related articles for article (PubMed ID: 30118782)
21. Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of
Boiko AS; Ivanova SA; Pozhidaev IV; Freidin MB; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM
World J Biol Psychiatry; 2020 Jan; 21(1):72-77. PubMed ID: 30623717
[No Abstract] [Full Text] [Related]
22. Genetics of tardive dyskinesia: Promising leads and ways forward.
Zai CC; Maes MS; Tiwari AK; Zai GC; Remington G; Kennedy JL
J Neurol Sci; 2018 Jun; 389():28-34. PubMed ID: 29502799
[TBL] [Abstract][Full Text] [Related]
23. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
Bordia T; Zhang D; Perez XA; Quik M
Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
[TBL] [Abstract][Full Text] [Related]
24. Analysis of genetic variations in the RGS9 gene and antipsychotic-induced tardive dyskinesia in schizophrenia.
Liou YJ; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Mo GH; Lai IC
Am J Med Genet B Neuropsychiatr Genet; 2009 Mar; 150B(2):239-42. PubMed ID: 18548510
[TBL] [Abstract][Full Text] [Related]
25. No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic-induced tardive dyskinesia.
Levchenko A; Vyalova N; Pozhidaev IV; Boiko AS; Osmanova DZ; Fedorenko OY; Semke AV; Bokhan NA; Wilffert B; Loonen AJM; Ivanova SA
Hum Psychopharmacol; 2019 Jan; 34(1):e2685. PubMed ID: 30623492
[TBL] [Abstract][Full Text] [Related]
26. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
[TBL] [Abstract][Full Text] [Related]
27. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites?
Koola MM; Tsapakis EM; Wright P; Smith S; Kerwin Rip RW; Nugent KL; Aitchison KJ
J Psychopharmacol; 2014 Jul; 28(7):665-70. PubMed ID: 24595968
[TBL] [Abstract][Full Text] [Related]
28. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
29. Tardive Dyskinesia Development, Superoxide Dismutase Levels, and Relevant Genetic Polymorphisms.
Uludag K; Wang DM; Zhang XY
Oxid Med Cell Longev; 2022; 2022():5748924. PubMed ID: 36338339
[TBL] [Abstract][Full Text] [Related]
30. A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia.
Levchenko A; Kanapin A; Samsonova A; Fedorenko OY; Kornetova EG; Nurgaliev T; Mazo GE; Semke AV; Kibitov AO; Bokhan NA; Gainetdinov RR; Ivanova SA
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110134. PubMed ID: 33065217
[TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.
Witter DP; Holbert RC; Suryadevara U
Expert Opin Pharmacother; 2017 Jul; 18(10):965-972. PubMed ID: 28443349
[TBL] [Abstract][Full Text] [Related]
32. No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients.
Park YM; Kang SG; Choi JE; Kim YK; Kim SH; Park JY; Kim L; Lee HJ
Psychiatry Investig; 2011 Mar; 8(1):49-54. PubMed ID: 21519536
[TBL] [Abstract][Full Text] [Related]
33. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
Seigneurie AS; Sauvanaud F; Limosin F
Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
[TBL] [Abstract][Full Text] [Related]
34. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
[TBL] [Abstract][Full Text] [Related]
35. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
Chan CH; Chan HY; Chen YC
Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
[TBL] [Abstract][Full Text] [Related]
37. Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
Koning JP; Vehof J; Burger H; Wilffert B; Al Hadithy A; Alizadeh B; van Harten PN; Snieder H;
Psychopharmacology (Berl); 2012 Feb; 219(3):727-36. PubMed ID: 21750899
[TBL] [Abstract][Full Text] [Related]
38. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
39. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
[TBL] [Abstract][Full Text] [Related]
40. Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.
Punchaichira TJ; Mukhopadhyay A; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
J Psychopharmacol; 2020 Mar; 34(3):358-369. PubMed ID: 31913053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]